ASCEND
BY NTHRYS

NTHRYSPhD AssistanceNeuropathology

Neuropathology

Field
Category

Neuropathology

Select a category to explore research frontiers

Neuropathology200 categories·80 research gap frontiers·access £41
UIRG Unique Individual Research GapFrontier Research Gap Frontier, groups 3+ UIRGsChip badge 4 UIRGs in that frontier🔓 One fee unlocks every UIRG under a frontier🧬 Illustrated: graphical abstract published
PathFieldCategoryFrontierUIRGPhD assistance services
Amyloid-Beta Aggregation Mechanisms and Toxicity
10 frontiers
10+
UIRGS
Investigation of pathological protein folding and oligomerization processes underlying Alzheimer''s disease neuropathology.
RESEARCH GAP FRONTIERS
Oligomeric Amyloid-Beta as a Toxic Intermediate StateSeeded Aggregation and Prion-like Propagation of Amyloid-BetaAmyloid-Beta Fibril Polymorphism and Neurotoxic Heterogeneity+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Tau Phosphorylation and Neurofibrillary Tangle Formation
10 frontiers
10+
UIRGS
Examination of hyperphosphorylated tau protein dynamics and the molecular mechanisms driving pathological tangle propagation.
RESEARCH GAP FRONTIERS
Kinase-Specific Tau Phosphorylation Signatures in NeurodegenerationPrion-Like Propagation of Pathological Tau ConformersTau Hyperphosphorylation at the Synapse-to-Soma Axis+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Alpha-Synuclein Misfolding in Parkinson''s Disease
10 frontiers
10+
UIRGS
Analysis of Lewy body formation and prion-like propagation mechanisms of alpha-synuclein in neurodegeneration.
RESEARCH GAP FRONTIERS
Prion-like Propagation of Alpha-Synuclein Across Neural NetworksSeeding and Templating in Alpha-Synuclein Fibril FormationOligomeric Intermediates as Toxic Species in Parkinson's Pathogenesis+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Neuroinflammation and Microglial Activation Pathways
10 frontiers
10+
UIRGS
Study of innate immune responses and microglia-mediated neuronal damage in neurodegenerative diseases.
RESEARCH GAP FRONTIERS
Microglial Metabolic Switching in Neuroinflammatory StatesDanger-Associated Molecular Patterns and Microglial PrimingComplement-Microglia Nexus in Synaptic Elimination+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Frontotemporal Dementia Molecular Pathology
10 frontiers
10+
UIRGS
Investigation of tau and TDP-43 pathology variants in frontotemporal lobar degeneration subtypes.
RESEARCH GAP FRONTIERS
Pathological Phase Separation in TDP-43 AggregationTau Isoform Switching and Neuronal Vulnerability GradientsProteostatic Collapse at the Frontotemporal Interface+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Huntington''s Disease Polyglutamine Toxicity
10 frontiers
10+
UIRGS
Examination of mutant huntingtin protein aggregation and cellular dysfunction in striatal neurodegeneration.
RESEARCH GAP FRONTIERS
Proteostatic Collapse in Polyglutamine-Expanded NeuronsNuclear Inclusions as Selective Vulnerability HubsTranscriptional Dysregulation by Mutant Huntingtin Oligomers+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Amyotrophic Lateral Sclerosis Motor Neuron Degeneration
10 frontiers
10+
UIRGS
Study of SOD1, FUS, and C9orf72 mutations driving motor cortex and spinal cord pathology.
RESEARCH GAP FRONTIERS
Axonal Transport Collapse and Proteostatic Cascades in Motor NeuronsRNA Dysmetabolism at the Neuromuscular Junction InterfaceGlial-Neuronal Metabolic Coupling in Motor Neuron Vulnerability+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Prion Disease Propagation and Conversion
10 frontiers
10+
UIRGS
Investigation of pathogenic prion protein conformational changes and transmissible spongiform encephalopathy mechanisms.
RESEARCH GAP FRONTIERS
Prion Strain Heterogeneity and Phenotypic PlasticityProtein Misfolding Amplification at the Blood-Brain BarrierNeuroinflammatory Cascades in Prion Transmission+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Mitochondrial Dysfunction in Neurodegeneration
Analysis of mitochondrial morphology, bioenergetics, and quality control failures in neuronal cell death pathways.
Explore frontiers →
Lysosomal Storage Diseases Neuropathology
Study of pathological accumulation of lipids and glycans in neuronal lysosomes in genetic storage disorders.
Explore frontiers →
Cerebral Amyloid Angiopathy and Vascular Pathology
Examination of amyloid deposition in blood vessel walls and resulting hemorrhagic complications.
Explore frontiers →
Synaptic Dysfunction and Dendritic Spine Pathology
Investigation of pre- and post-synaptic structural changes and loss in cognitive decline diseases.
Explore frontiers →
Axonal Degeneration and Neuronal Transport Defects
Study of impaired axonal transport mechanisms and axonopathy in neurodegenerative pathological conditions.
Explore frontiers →
Neuroinclusions and Protein Aggregation Disorders
Analysis of intracellular and extracellular inclusion formation across multiple neurodegenerative disease types.
Explore frontiers →
Glial Scar Formation and Astrocytic Responses
Examination of post-injury reactive astrogliosis and its dual effects on neuroprotection and neuroinflammation.
Explore frontiers →
White Matter Pathology and Demyelination
Investigation of oligodendrocyte loss and myelin breakdown in progressive neurological disorders.
Explore frontiers →
Copper and Iron Accumulation in Neurodegeneration
Study of metal dysregulation and oxidative stress in age-related neurodegenerative disease pathogenesis.
Explore frontiers →
Oxidative Stress and Free Radical Damage Pathways
Examination of reactive oxygen species generation and antioxidant system failure in neuronal death.
Explore frontiers →
Autophagy Impairment in Neuronal Homeostasis
Investigation of macroautophagy and chaperone-mediated autophagy dysfunction in protein clearance diseases.
Explore frontiers →
Proteasomal System Dysfunction and UPS Failure
Study of ubiquitin-proteasome system breakdown and its contribution to protein accumulation pathology.
Explore frontiers →
Neuronal Cell Death Mechanisms and Apoptosis
Analysis of caspase-dependent and caspase-independent neuronal death pathways in degeneration.
Explore frontiers →
Excitotoxicity and Glutamate Receptor Dysfunction
Examination of calcium overload and exitotoxic injury mechanisms in neurodegenerative conditions.
Explore frontiers →
Vascular Contributions to Cognitive Impairment
Investigation of cerebral hypoperfusion and blood-brain barrier breakdown in mixed dementia pathology.
Explore frontiers →
Traumatic Brain Injury Chronic Sequelae
Study of post-traumatic neurodegeneration and chronic traumatic encephalopathy neuropathology.
Explore frontiers →
Viral Infection and Neuroinflammatory Neuropathology
Analysis of virus-induced neuronal damage and secondary neurodegeneration mechanisms.
Explore frontiers →
Multiphoton and Two-Photon Microscopy in Neuropathology
Development and application of advanced imaging techniques for high-resolution pathological analysis.
Explore frontiers →
Digital Pathology and Artificial Intelligence Integration
Implementation of machine learning algorithms and computational analysis for quantitative neuropathology.
Explore frontiers →
High-Resolution Immunohistochemistry Methodology
Development of multiplexed staining and improved antibody detection techniques for pathological markers.
Explore frontiers →
Mass Spectrometry Proteomics in Brain Pathology
Application of tandem mass spectrometry for comprehensive protein identification in diseased tissue.
Explore frontiers →
Single-Cell RNA Sequencing in Neuropathology
Investigation of transcriptional changes at cellular resolution in degenerating neural tissues.
Explore frontiers →
Spatial Transcriptomics and In Situ Hybridization
Study of gene expression distribution patterns while preserving tissue architecture in pathological samples.
Explore frontiers →
Electron Microscopy and Ultrastructural Analysis
Ultra-high resolution examination of subcellular pathological changes and organellar dysfunction.
Explore frontiers →
Organoid Models of Neurodegenerative Disease
Development of three-dimensional brain tissue models to recapitulate disease pathology in vitro.
Explore frontiers →
Transgenic Mouse Models of Neuropathology
Generation and characterization of genetically-modified animal models expressing human disease mutations.
Explore frontiers →
Patient-Derived Induced Pluripotent Stem Cells
Reprogramming of patient fibroblasts into neural cells to model disease-specific neuropathology.
Explore frontiers →
Post-Mortem Brain Tissue Biobanking Standards
Establishment of protocols for optimal tissue collection, preservation, and standardization in research.
Explore frontiers →
Cerebrospinal Fluid Biomarker Discovery and Validation
Identification and clinical validation of CSF protein markers reflecting underlying neuropathology.
Explore frontiers →
Blood-Brain Barrier Integrity and Breakdown
Investigation of tight junction protein disruption and vascular permeability in neurodegeneration.
Explore frontiers →
Neuroplasticity and Compensatory Mechanisms
Study of adaptive neural rewiring and resilience pathways that offset pathological damage.
Explore frontiers →
Astrocyte Dysfunction in Neurodegenerative Disease
Examination of impaired metabolic support and neurotropic factor production by reactive astrocytes.
Explore frontiers →
Oligodendrocyte Pathology and Myelin Dysfunction
Investigation of myelin-forming cell degeneration and secondary axonal damage mechanisms.
Explore frontiers →
Microvasculature Degeneration and Capillary Loss
Study of brain capillary rarefaction and endothelial cell dysfunction in cognitive decline.
Explore frontiers →
Perivascular Space Pathology and Lymphatic Clearance
Analysis of perivascular inflammation and glymphatic system dysfunction in protein clearance failures.
Explore frontiers →
Genetic Modifier Loci in Neuropathology Susceptibility
Identification of genomic variants that modulate disease penetrance and pathological severity.
Explore frontiers →
Epigenetic Modifications in Neurodegeneration
Study of DNA methylation and histone acetylation changes driving disease-specific gene expression.
Explore frontiers →
MicroRNA Dysregulation in Brain Pathology
Investigation of altered microRNA expression patterns and their post-transcriptional effects on neuronal health.
Explore frontiers →
Seeding and Prion-Like Propagation of Pathological Proteins
Examination of cell-to-cell transmission mechanisms for misfolded protein spreading between neurons.
Explore frontiers →
Neuroinflammatory Cascade Initiation and Amplification
Study of danger signals and innate immune pathway activation leading to chronic neuroinflammation.
Explore frontiers →
Neuropathological Subtyping and Disease Classification
Development of pathology-based biomarker criteria for improved disease categorization and prognosis.
Explore frontiers →
Aging Brain and Senescent Cell Accumulation
Investigation of age-related cellular senescence and its contribution to neurodegeneration.
Explore frontiers →
Liquid Biopsy Biomarkers in Neurodegeneration
Investigation of pathological protein detection in blood and other bodily fluids as non-invasive diagnostic and prognostic tools for neurodegenerative diseases.
Explore frontiers →
Neuronal Circuit Disruption and Network Pathology
Study of how disease-related pathological changes disrupt functional connectivity and neural circuit organization in affected brain regions.
Explore frontiers →
TDP-43 Cytoplasmic Inclusions and ALS Pathogenesis
Analysis of TAR DNA-binding protein 43 mislocalization, aggregation, and its role in motor neuron vulnerability and ALS progression.
Explore frontiers →
Neuroinflammatory Priming and Pathological Vulnerability
Examination of how chronic low-grade neuroinflammation predisposes brain tissue to accelerated pathological progression and neurodegeneration.
Explore frontiers →
Protein Seeding in Inter-Regional Brain Spread
Investigation of mechanisms controlling template-directed pathological protein propagation between anatomically connected brain regions.
Explore frontiers →
Metabolic Dysfunction in Diseased Neurons
Study of altered glucose metabolism, lipid homeostasis, and bioenergetic failure underlying neuronal degeneration and cell death.
Explore frontiers →
Neuropathological Heterogeneity in Alzheimer Disease
Characterization of distinct amyloid, tau, and TDP-43 pathology combinations defining different Alzheimer disease pathological subtypes.
Explore frontiers →
Endosomal-Lysosomal System Disruption
Analysis of impaired endocytic trafficking and lysosomal degradation contributing to neuroinflammation and protein accumulation.
Explore frontiers →
Neuroinflammatory Mediators and Cytokine Signaling
Exploration of pro-inflammatory and anti-inflammatory cytokine pathways driving glial activation and neuronal damage.
Explore frontiers →
Calcium Homeostasis Dysregulation in Neurodegeneration
Investigation of abnormal intracellular and extracellular calcium signaling leading to neuronal dysfunction and cell death.
Explore frontiers →
Post-Translational Modifications in Tau Pathology
Study of phosphorylation, ubiquitination, acetylation, and other modifications regulating tau aggregation and toxicity.
Explore frontiers →
Neuroinflammatory Response to Pathological Proteins
Characterization of glial recognition and immune responses triggered by misfolded protein accumulation in brain tissue.
Explore frontiers →
Perivascular Inflammation and Blood-Brain Barrier
Examination of immune cell infiltration, BBB disruption, and perivascular inflammation in neurodegenerative pathology.
Explore frontiers →
Neuronal Vulnerability and Cell-Type Specificity
Investigation of why specific neuronal populations are preferentially affected in different neurodegenerative diseases.
Explore frontiers →
RNA-Binding Protein Dysfunction and Toxicity
Study of pathological RNA-binding protein aggregation and dysregulated RNA metabolism in neurodegeneration.
Explore frontiers →
FUS Pathology in Frontotemporal Dementia
Analysis of fused in sarcoma protein mislocalization, cytoplasmic inclusions, and neurotoxicity in FUS-associated dementia.
Explore frontiers →
Stress Granule Formation and Neurodegeneration
Investigation of pathological stress granule assembly and dysregulation in neurodegenerative protein aggregation diseases.
Explore frontiers →
Oligomeric Pathological Protein Toxicity
Characterization of toxic oligomeric intermediates formed during protein misfolding and their mechanisms of neuronal damage.
Explore frontiers →
Synaptic Loss and Synaptotoxicity Mechanisms
Study of how pathological proteins directly damage synapses and impair synaptic plasticity underlying cognitive decline.
Explore frontiers →
Neuroinflammatory Biomarker Development and Validation
Discovery and clinical validation of glial activation markers and inflammatory mediators as disease progression indicators.
Explore frontiers →
Corticospinal Tract Degeneration in ALS
Neuropathological characterization of upper motor neuron loss and white matter pathology in amyotrophic lateral sclerosis.
Explore frontiers →
Lewy Body Pathology Distribution and Burden
Mapping and quantification of alpha-synuclein inclusions across brain regions in Parkinson disease and related disorders.
Explore frontiers →
Cerebellum Pathology in Neurodegenerative Disease
Investigation of cerebellar neuronal loss, gliosis, and pathological protein accumulation in ataxias and dementia.
Explore frontiers →
Brainstem Pathology and Motor System Degeneration
Study of pathological changes in substantia nigra, locus coeruleus, and other brainstem nuclei in parkinsonism.
Explore frontiers →
Hippocamp Vulnerability in Neurodegeneration
Neuropathological analysis of selective hippocampal neuronal loss and pathology underlying memory impairment.
Explore frontiers →
Entorhinal Cortex Pathology and Memory Dysfunction
Characterization of early tau and amyloid pathology in entorhinal cortex and its role in memory disturbance.
Explore frontiers →
Prefrontal Cortex Degeneration and Cognitive Impairment
Investigation of executive function decline and behavioral changes resulting from prefrontal cortical pathology.
Explore frontiers →
Basal Ganglia Pathology in Movement Disorders
Analysis of striatal and pallidal pathological changes underlying motor symptoms in Huntington and Parkinson disease.
Explore frontiers →
Purkinje Cell Degeneration and Cerebellar Ataxia
Neuropathological study of selective Purkinje cell loss and granule cell changes in inherited ataxia disorders.
Explore frontiers →
Spinal Cord Pathology in Motor Neuron Disease
Characterization of anterior horn cell loss and gliosis in the spinal cord of ALS and related disorders.
Explore frontiers →
Peripheral Nerve Pathology in Neurodegeneration
Investigation of axonal degeneration and demyelination in peripheral nerves associated with CNS disease.
Explore frontiers →
Neurovascular Unit Dysfunction and Pathology
Study of coordinated pathological changes in endothelial cells, pericytes, and glial cells affecting brain perfusion.
Explore frontiers →
Pericyte Loss and Capillary Regression
Analysis of pericyte degeneration and capillary drop-out contributing to hypoperfusion and neurodegeneration.
Explore frontiers →
Cerebral Microinfarcts and Ischemic Pathology
Investigation of silent cerebral infarcts and chronic hypoperfusion in mixed dementia pathology.
Explore frontiers →
Neuroinflammatory Contribution to Vascular Pathology
Study of how neuroinflammation promotes vascular dysfunction and cerebral amyloid angiopathy progression.
Explore frontiers →
Astrocyte Reactivity and Disease Progression
Characterization of A1 and A2 astrocyte phenotypes and their roles in neurodegeneration versus neuroprotection.
Explore frontiers →
Microglial Polarization and Neuroinflammatory States
Investigation of pro-inflammatory M1 and anti-inflammatory M2 microglial activation states in pathology.
Explore frontiers →
Oligodendrocyte Loss and White Matter Gliosis
Study of oligodendrocyte death and reactive gliosis contributing to white matter degeneration and myelin loss.
Explore frontiers →
Ependymal Cell Dysfunction and CSF Pathology
Analysis of impaired ependymal cell function affecting cerebrospinal fluid flow and glymphatic clearance.
Explore frontiers →
Glymphatic System Dysfunction in Neurodegeneration
Investigation of impaired interstitial fluid drainage and protein clearance through the glymphatic system.
Explore frontiers →
Meningeal Inflammation and Immune Cell Infiltration
Study of meningeal T cell and B cell populations and their contribution to neuroinflammatory pathology.
Explore frontiers →
Choroid Plexus Dysfunction and BBB Breakdown
Characterization of choroid plexus epithelial pathology and its role in compromised blood-CSF barrier function.
Explore frontiers →
Neuronal Morphological Changes and Pathology
Analysis of soma atrophy, dendritic beading, axonal swelling, and other morphological abnormalities in disease.
Explore frontiers →
Granulovacuolar Degeneration and Neuronal Inclusions
Investigation of age-related granulovacuolar degeneration and Pick bodies in various tauopathies.
Explore frontiers →
Neuropil Threads and Thread Pathology
Study of abnormal neurite morphology and tau-containing neuropil thread formation in neurodegenerative disease.
Explore frontiers →
Hirano Bodies and Cytoskeletal Pathology
Characterization of actin-based paracrystalline inclusions and their relationship to neurodegeneration.
Explore frontiers →
Rod-Like Structures and Stress Response Pathology
Analysis of abnormal neurofilament arrangements and rod-like inclusions in response to neuronal stress.
Explore frontiers →
Neuritic Plaques and Amyloid Accumulation
Investigation of dystrophic neurite formation around amyloid plaques and associated pathological changes.
Explore frontiers →
Amyloid Plaque Morphology and Heterogeneity
Characterization of diffuse versus neuritic plaque types and their distinct neuropathological features and toxicity.
Explore frontiers →
Tangle Morphology and Tau Strain Variants
Study of distinct tau fibril conformations producing different neuropathological patterns and disease phenotypes.
Explore frontiers →
Tau Pathology Spreading and Cell-to-Cell Transmission
Investigation of mechanisms underlying tau protein propagation between neurons and glial cells through extracellular vesicles and synaptic connections in tauopathies.
Explore frontiers →
TDP-43 Cytoplasmic Inclusions and RNA Dysregulation
Characterization of TAR DNA-binding protein 43 mislocalization, aggregation patterns, and consequent dysregulation of RNA splicing and stability in neurodegeneration.
Explore frontiers →
Neuroinflammatory Signatures and Proteomic Profiling
Mass spectrometry-based identification of inflammatory cytokine and chemokine signatures in cerebrospinal fluid and brain tissue from neurodegenerative disease patients.
Explore frontiers →
Leukoaraiosis and Age-Related White Matter Degeneration
Neuropathological characterization of age-dependent white matter hyperintensities, oligodendrocyte loss, and myelin breakdown associated with cognitive decline.
Explore frontiers →
Amyloid-Independent Neurodegeneration Pathways
Investigation of alternative molecular mechanisms driving neuronal death and cognitive impairment in the absence of classical amyloid-beta pathology.
Explore frontiers →
Neuropathological Heterogeneity in Alzheimer Disease
Characterization of distinct pathological subtypes and atypical presentations of Alzheimer disease based on regional distribution and severity of tau and amyloid pathology.
Explore frontiers →
Frontotemporal Dementia Pathology-Phenotype Correlations
Systematic neuropathological analysis of clinicopathological correlations between tau, TDP-43, and FUS pathologies and specific cognitive and behavioral phenotypes.
Explore frontiers →
Neuronal Lipofuscin Accumulation and Aging
Investigation of age-dependent accumulation of non-degradable lipid-protein complexes in neurons and its relationship to cellular dysfunction and neurodegeneration.
Explore frontiers →
Stress Granule Dynamics in Neurodegeneration
Characterization of aberrant stress granule formation, persistence, and composition in neurodegenerative diseases involving TDP-43 and other RNA-binding proteins.
Explore frontiers →
Synaptic Loss Quantification and Network Analysis
Development of three-dimensional reconstruction methods and computational approaches to quantify synapse density, morphology, and connectivity in diseased brain tissue.
Explore frontiers →
Perivascular Amyloid Deposition and Cerebral Microhemorrhages
Analysis of amyloid accumulation in vessel walls, associated vessel rupture, microhemorrhage formation, and vascular cognitive impairment mechanisms.
Explore frontiers →
Neuroinflammatory Phenotyping of Resident Microglia
Single-cell transcriptomic and morphological characterization of microglial activation states and pro- versus anti-inflammatory phenotypes in neurodegenerative conditions.
Explore frontiers →
Neuronal Calcium Dysregulation and Excitotoxic Cascades
Investigation of calcium homeostasis disruption, excitatory amino acid accumulation, and downstream excitotoxic signaling in neurodegenerative pathology.
Explore frontiers →
Protein-Specific Pathology in Mixed Dementia
Neuropathological quantification and spatial mapping of multiple co-occurring protein pathologies including amyloid, tau, TDP-43, and alpha-synuclein in single brains.
Explore frontiers →
Cerebellar Pathology in Neurodegenerative Disease
Characterization of cerebellar neurodegeneration patterns, Purkinje cell loss, granule cell abnormalities, and their contribution to cognitive and motor impairment.
Explore frontiers →
Spinal Cord Pathology in Cognitive Disorders
Investigation of protein aggregation, neuroinflammation, and neuronal loss in spinal cord tissue from patients with Alzheimer disease and other tauopathies.
Explore frontiers →
Pericyte Dysfunction and Vascular Collapse
Analysis of pericyte coverage loss, blood-brain barrier breakdown, capillary occlusion, and vascular insufficiency in neurodegeneration.
Explore frontiers →
Choroid Plexus Pathology and CSF Dynamics
Neuropathological examination of choroid plexus epithelial dysfunction, cerebrospinal fluid production impairment, and clearance pathway alterations in neurodegeneration.
Explore frontiers →
Retinal Neuropathology as Biomarker for CNS Disease
Investigation of retinal neurodegeneration patterns, retinal protein aggregation, and retinal vascular changes as accessible biomarkers for central nervous system pathology.
Explore frontiers →
Olfactory Bulb Pathology in Neurodegeneration
Analysis of early pathological changes in olfactory epithelium and bulb, including protein aggregation and neuronal loss, in neurodegenerative disease models.
Explore frontiers →
Post-Translational Modification Cross-Linking Mechanisms
Study of abnormal protein cross-linking through ubiquitination, SUMOylation, phosphorylation, and other post-translational modifications promoting pathological aggregation.
Explore frontiers →
Seed Prion-Like Propagation and Templating
Investigation of misfolded protein seeds as self-propagating templates, structural features enabling propagation, and mechanisms of conformational templating in disease spread.
Explore frontiers →
Exosome-Mediated Protein Transfer and Pathology Spread
Characterization of extracellular vesicle production, cargo loading, intercellular transfer, and role in spreading pathological proteins between neural cells.
Explore frontiers →
Astrocytic Activation and Inflammatory Cytokine Production
Analysis of reactive astrocyte morphology, transcriptional reprogramming, and contribution to neuroinflammatory cascade through cytokine and chemokine secretion.
Explore frontiers →
Oligodendrocyte Precursor Cell Dysfunction and Remyelination Failure
Investigation of oligodendrocyte precursor cell activation impairment, maturation defects, and failure of endogenous remyelination in white matter pathology.
Explore frontiers →
Blood Biomarkers and Protein Detection Assays
Development and validation of ultrasensitive immunoassays for detecting pathological proteins, phosphorylated species, and aggregates in plasma and serum samples.
Explore frontiers →
Imaging Mass Spectrometry and Spatial Proteomics
Application of mass spectrometry imaging to generate spatial maps of protein distribution, post-translational modifications, and molecular interactions within brain tissue sections.
Explore frontiers →
Lipidomics and Lipid Metabolism Dysregulation
Comprehensive analysis of altered lipid composition, dysregulated lipid metabolism, and lipid-protein interactions in neurodegeneration using mass spectrometry approaches.
Explore frontiers →
Metabolomics and Bioenergetic Failure Signatures
Investigation of altered metabolite levels, impaired mitochondrial metabolism, and bioenergetic dysfunction in brain tissue and body fluids of neurodegenerative disease patients.
Explore frontiers →
3D Organoid Development and Disease Modeling
Generation of brain organoids from patient-derived iPSCs that recapitulate neuropathological hallmarks and enable study of disease mechanisms in three-dimensional contexts.
Explore frontiers →
Neural Circuit Dysfunction in Disease Models
Electrophysiological and imaging analysis of circuit-level dysfunction, disrupted connectivity, and impaired network oscillations in transgenic and iPSC-based disease models.
Explore frontiers →
Tau Hyperphosphorylation and Kinase-Phosphatase Imbalance
Investigation of kinase dysregulation, phosphatase inhibition, and resulting abnormal tau phosphorylation patterns in specific residues across disease pathogenesis.
Explore frontiers →
Alpha-Synuclein Conformational Variants and Toxicity
Characterization of distinct alpha-synuclein conformational states, their propagation properties, and differential cellular toxicity mechanisms across synucleinopathies.
Explore frontiers →
Neuronal-Glial Metabolic Coupling and Lactate Shuttling
Investigation of metabolic interactions between neurons and glia, lactate production and utilization, and metabolic failure in neurodegeneration.
Explore frontiers →
Protein Aggregation Kinetics and Structural Evolution
Biophysical characterization of aggregation mechanisms, kinetic modeling, structural evolution from oligomers to fibrils, and strain-like properties of protein aggregates.
Explore frontiers →
Morphological Plasticity and Dendritic Remodeling
Analysis of dendritic spine dynamics, dendritic arbor remodeling, axonal varicosities, and morphological alterations associated with pathological protein accumulation.
Explore frontiers →
Subcellular Pathology and Compartment-Specific Dysfunction
Investigation of protein aggregation within specific cellular compartments including nucleus, cytoplasm, axon initial segment, and axon terminal, and their functional consequences.
Explore frontiers →
Sex Differences and Hormone-Dependent Neuropathology
Examination of sex-dependent differences in neuropathological burden, severity patterns, and role of sex hormones in modulating neurodegeneration and inflammation.
Explore frontiers →
Ethnic and Genetic Ancestry Effects on Pathology
Investigation of population-specific differences in neuropathological patterns, genetic risk factor prevalence, and pathological thresholds across ancestral groups.
Explore frontiers →
Resilience and Cognitive Reserve Neuropathological Substrates
Neuropathological characterization of structural and biochemical features in cognitively preserved individuals with high pathological burden, identifying protective mechanisms.
Explore frontiers →
Developmental Genetics and Fetal Neuropathology
Investigation of developmental gene expression patterns, their dysregulation in disease, and fetal brain vulnerability to inherited neuropathological predisposition.
Explore frontiers →
Environmental Toxin Exposure and Neuropathological Synergy
Study of how environmental neurotoxicants interact with genetic factors to accelerate pathological protein accumulation and neurodegeneration.
Explore frontiers →
Infection-Associated Neuroinflammation and Neurodegeneration
Investigation of how acute and chronic infections trigger sustained neuroinflammation, pathological protein aggregation, and long-term neurodegeneration.
Explore frontiers →
Post-Traumatic Neurodegeneration and Chronic TBI Pathology
Characterization of neuropathological changes following traumatic brain injury including tau, amyloid accumulation, neuroinflammation, and progressive neurodegeneration.
Explore frontiers →
Neurodegeneration in Psychiatric and Mood Disorders
Investigation of shared neuropathological mechanisms between neurodegenerative diseases and psychiatric conditions including depression, bipolar disorder, and psychosis.
Explore frontiers →
Sleep-Wake Cycle Disruption and Glymphatic Dysfunction
Study of how sleep architecture alterations impair glymphatic clearance, enable pathological protein accumulation, and accelerate neurodegeneration.
Explore frontiers →
Circadian Rhythm Dysregulation and Neuropathology
Investigation of clock gene dysfunction, circadian disruption, and consequences for neuroinflammation, protein aggregation, and neurodegeneration.
Explore frontiers →
Microbiome-Brain Axis and Neurodegeneration
Characterization of gut microbiota composition changes, barrier dysfunction, lipopolysaccharide translocation, and role in driving neuroinflammation and pathology spread.
Explore frontiers →
Liquid-Liquid Phase Separation in Pathological Aggregation
Investigation of phase separation of proteins and RNA into membraneless organelles and its dysregulation leading to pathological aggregation in neurodegeneration.
Explore frontiers →
Autophagy Substrate Selectivity and Pathological Clearance
Study of selective autophagy pathways for degrading pathological proteins, mutations affecting substrate recognition, and impaired clearance mechanisms in disease.
Explore frontiers →
Protein Liquid-Liquid Phase Separation Pathology
Investigation of aberrant biomolecular condensates and phase separation phenomena in neurodegenerative disease pathogenesis and neuronal dysfunction.
Explore frontiers →
Extracellular Vesicle Biomarkers in Neurodegeneration
Analysis of exosomes and microvesicles as carriers of pathological proteins and diagnostic markers in neurodegenerative diseases.
Explore frontiers →
Endoplasmic Reticulum Stress and Unfolded Protein Response
Study of ER dysfunction, PERK-eIF2α signaling, and UPR dysregulation in neuronal pathology and disease progression.
Explore frontiers →
TDP-43 Proteinopathy Across Neurodegenerative Diseases
Comprehensive examination of TAR DNA-binding protein 43 mislocalization, phosphorylation, and aggregation in ALS and frontotemporal dementia.
Explore frontiers →
FUS RNA-Binding Protein Dysfunction and Toxicity
Investigation of fused in sarcoma protein aggregation and aberrant RNA processing in familial ALS pathogenesis.
Explore frontiers →
Neuronal Calcium Dysregulation and Excitotoxic Cascades
Examination of disrupted calcium homeostasis, NMDAR dysfunction, and calcium-dependent protease activation in neurodegeneration.
Explore frontiers →
Choroid Plexus Dysfunction and CSF Flow Pathology
Analysis of impaired cerebrospinal fluid production, glymphatic system dysfunction, and solute clearance in neurodegeneration.
Explore frontiers →
Neuronal Senescence and Cellular Aging Markers
Study of senescence-associated secretory phenotype, p16INK4a expression, and cellular aging in neurodegenerative pathology.
Explore frontiers →
Neurovascular Unit Disruption and Angiogenic Failure
Investigation of pericyte loss, endothelial dysfunction, and impaired angiogenesis contributing to neurodegeneration.
Explore frontiers →
Neuroinflammatory Cytokine Profiling and Signaling
Comprehensive analysis of pro-inflammatory cytokine cascades, IL-1β, TNF-α, and IL-6 pathways in brain pathology.
Explore frontiers →
Immune Cell Infiltration and Lymphocyte-Mediated Pathology
Characterization of peripheral immune cell recruitment, T cell activation, and adaptive immunity contributions to neurodegeneration.
Explore frontiers →
Olig2-Positive Oligodendrocyte Progenitor Dysfunction
Study of impaired oligodendrocyte development, maturation failure, and remyelination deficits in neurodegenerative disease.
Explore frontiers →
Astrocytic A1/A2 Phenotype Classification in Pathology
Investigation of neurotoxic A1 astrocyte polarization versus neuroprotective A2 phenotypes in neuroinflammatory contexts.
Explore frontiers →
Microglial Metabolic Reprogramming in Neuroinflammation
Analysis of microglial glycolytic and oxidative metabolism shifts and metabolic-immune axis coupling in brain pathology.
Explore frontiers →
Complement System Activation and C3-Mediated Neuroinflammation
Study of classical, alternative, and lectin complement pathway activation and neuronal complement-dependent cytotoxicity.
Explore frontiers →
RNA Modifications and Epitranscriptomics in Neurodegeneration
Investigation of m6A methylation, pseudouridine, and other RNA modifications affecting neuronal RNA stability and translation.
Explore frontiers →
Histone Acetylation and Chromatin Remodeling in Neuropathology
Analysis of HDAC dysfunction, histone deacetylase inhibitor effects, and chromatin accessibility in neurodegenerative transcription.
Explore frontiers →
DNA Damage Response and Neuronal Genome Instability
Study of impaired DNA repair mechanisms, ATM-p53 signaling, and accumulation of DNA lesions in neurodegeneration.
Explore frontiers →
Synaptic Vesicle Release and Neurotransmitter Depletion
Investigation of SNARE complex dysfunction, vesicle pool depletion, and impaired acetylcholine and dopamine neurotransmission.
Explore frontiers →
Long-Term Potentiation and Depression Disruption
Examination of AMPAR trafficking, NMDAR-dependent plasticity failure, and synaptic strength alterations in cognitive decline.
Explore frontiers →
Postsynaptic Density Organization and Scaffolding Protein Loss
Study of PSD-95, SAP102, and other scaffolding protein abnormalities affecting synaptic transmission and neuronal connectivity.
Explore frontiers →
Neurotrophin Signaling Deficiency and Growth Factor Failure
Analysis of reduced BDNF production, impaired TrkB signaling, and p75NTR-mediated cell death in neurodegeneration.
Explore frontiers →
Vesicular Trafficking Defects and Golgi Pathology
Investigation of COPII-mediated secretion failure, Golgi fragmentation, and retrograde transport disruption in neuronal dysfunction.
Explore frontiers →
Lipid Peroxidation and Membrane Dysfunction Pathology
Study of oxidative lipid damage, cardiolipin depletion, and myelin lipid abnormalities in neurodegenerative disease.
Explore frontiers →
Neuroinflammatory Lipid Mediators and Eicosanoid Signaling
Analysis of arachidonic acid cascade, prostaglandin production, and lipoxin signaling in brain inflammation.
Explore frontiers →
Glucose Metabolism and Aerobic Glycolysis Failure
Investigation of impaired glucose uptake, lactate metabolism dysfunction, and neuronal bioenergetic crisis in neurodegeneration.
Explore frontiers →
Mitochondrial Biogenesis and PGC-1α Signaling Deficiency
Study of reduced mitochondrial biogenesis, impaired SIRT1-PGC-1α axis, and mitochondrial replacement failure.
Explore frontiers →
Ketone Metabolism and Alternative Energy Substrate Utilization
Examination of ketone body metabolism capacity, beta-hydroxybutyrate signaling, and metabolic flexibility in neurodegeneration.
Explore frontiers →
Neuronal Autophagy Substrate Selectivity and Cargo Recognition
Analysis of impaired selective autophagy, p62-ubiquitin aggregation pathways, and chaperone-mediated autophagy failure.
Explore frontiers →
Axosomal Transport Motor Protein Dysfunction
Investigation of kinesin and dynein motor defects, impaired retrograde transport, and accumulation of axonal cargo.
Explore frontiers →
Axonal Initial Segment Pathology and Sodium Channel Remodeling
Study of AIS structural breakdown, sodium channel redistribution, and neuronal excitability changes in disease.
Explore frontiers →
Neurofilament Aggregation and Cytoskeletal Collapse
Examination of phosphorylated neurofilament accumulation, microtubule destabilization, and actin dysfunction in neuronal degeneration.
Explore frontiers →
Histone Deacetylase Six Inhibition and Neuroprotection
Investigation of HDAC6 inhibition effects on alpha-synuclein and tau clearance, microtubule stability, and neuronal resilience.
Explore frontiers →
Brain-Derived Neurotrophic Factor Precursor Processing
Study of proBDNF versus mature BDNF signaling balance, furin-mediated cleavage, and activity-dependent secretion in neurodegeneration.
Explore frontiers →
Adenosine Triphosphate Depletion and Bioenergetic Collapse
Analysis of ATP synthase dysfunction, impaired oxidative phosphorylation, and cellular energy failure in neuronal pathology.
Explore frontiers →
Endosomal Sorting and Retromer Complex Dysfunction
Investigation of impaired VPS35-retromer function, failed cargo recycling, and accumulation in endosomal compartments.
Explore frontiers →
Cysteine Protease Activation and Calpain-Mediated Proteolysis
Study of calcium-dependent calpain activation, aberrant spectrin cleavage, and caspase-3 cascade initiation in neuronal death.
Explore frontiers →
Neuroinflammatory Toll-Like Receptor Signaling Pathways
Analysis of TLR4-MD2 recognition of pathological proteins, MyD88-dependent neuroinflammation, and TRIF-mediated immune responses.
Explore frontiers →
Sphingolipid Metabolism and Ceramide-Mediated Apoptosis
Investigation of impaired sphingomyelinase activity, ceramide accumulation, and ceramide-induced neuronal death pathways.
Explore frontiers →
Nicotinamide Adenine Dinucleotide Metabolism and Sirtuin Signaling
Study of NAD+ depletion, PARP-mediated NAD+ consumption, and impaired SIRT1-mediated neuroprotection in neurodegeneration.
Explore frontiers →
Purine and Pyrimidine Metabolism Dysfunction in Neurons
Examination of nucleotide pool depletion, impaired nucleotide synthesis, and DNA/RNA biosynthesis failure in neurodegeneration.
Explore frontiers →
Amino Acid Sensing and mTOR Signaling Dysregulation
Analysis of impaired amino acid sensing, dysregulated mTORC1 and mTORC2 signaling, and protein synthesis-autophagy balance.
Explore frontiers →
Neuronal Circadian Rhythm Disruption and Clock Gene Pathology
Investigation of circadian clock dysfunction, altered CLOCK and PER expression, and sleep-wake cycle pathology in neurodegeneration.
Explore frontiers →
Neuroimaging Pathology Correlation and In Vivo Neuropathological Staging
Study of structural MRI, PET imaging, and DWI correlations with postmortem neuropathological burden and disease staging.
Explore frontiers →
Connectomic Analysis and Network-Level Neuronal Pathology
Investigation of connectome mapping, circuit-level pathology propagation, and network vulnerability in neurodegeneration.
Explore frontiers →
Quantitative Morphometry and Three-Dimensional Stereological Analysis
Analysis of stereological volume estimation, neuronal density quantification, and morphometric changes in neurodegenerative brain tissue.
Explore frontiers →
Laser Capture Microdissection and Regional Proteomics
Study of region-specific protein expression patterns, layer-specific neuropathology, and microenvironment-dependent proteome alterations.
Explore frontiers →
Multiplexed Immunofluorescence and High-Dimensional Imaging
Investigation of simultaneous multi-epitope detection, multiplex antibody staining, and high-parameter neuropathological phenotyping.
Explore frontiers →
Biofluid Protein Biomarker Discovery and Longitudinal Tracking
Analysis of plasma phosphorylated tau, phosphorylated alpha-synuclein, and neurofilament light chain progression in neurodegeneration.
Explore frontiers →
Transcriptomic Profiling and Disease-Specific Gene Expression Signatures
Study of bulk and single-cell transcriptomics, cell-type-specific gene dysregulation, and pathway enrichment in neuropathology.
Explore frontiers →